Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;27(8S):S812-S813.
doi: 10.1097/RHU.0000000000001450.

Nailfold Videocapillaroscopy: A Diagnostic Tool When Clinical Evaluation Is Misleading

Affiliations

Nailfold Videocapillaroscopy: A Diagnostic Tool When Clinical Evaluation Is Misleading

Yora Mostmans et al. J Clin Rheumatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Hermann W. Capillaroscopy in rheumatoid arthritis and Sjögren syndrome. In: Cutolo M, editor. Atlas of Capillaroscopy in Rheumatic Diseases . Milan, Italy: Elsevier; 2017. p. 162–163.
    1. Smith V, Vanhaecke A, Herrick AL, et al. Fast track algorithm: how to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”. Autoimmun Rev . 2019;11:102394.
    1. Valentini G, Marcoccia A, Cuomo G, et al. The concept of early systemic sclerosis following 2013 ACR/EULAR criteria for the classification of systemic sclerosis. Curr Rheumatol Rev . 2014;10:38–44.
    1. Jordan S, Distler JHW, Maurer B, et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis . 2014;74:1188–1194.
    1. Smith V, Pizzorni C, Riccieri V, et al. Stabilization of microcirculation in patients with early systemic sclerosis with diffuse skin involvement following rituximab treatment: an open-label study. J Rheumatol . 2016;43:995–996.

LinkOut - more resources